SCHEMBL5579490

SCHEMBL5579490

Cc1cccc2nc3ccccc3n12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.47
KDM4E B2RXH2 4/20 0.46
POLB P06746 4/20 0.46
HSD17B10 Q99714 3/20 0.46
TP53 P04637 2/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
HTT P42858 2/20 0.45
HPGD P15428 4/20 0.42
ALDH1A1 P00352 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42
PDE2A O00408 2/20 0.42
PDE10A Q9Y233 2/20 0.42
MAPK1 P28482 1/20 0.42
PTPN2 P17706 1/20 0.42
PTPN1 P18031 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31031213 0.77 PDE10A (0.39) PKMKDM4EPOLBHSD17B10TP53
SCHEMBL22354956 0.75 KDM4E (0.45) KDM4EPOLBHSD17B10TP53LMNA
SCHEMBL29822663 0.74 KDM4E (0.46) PKMKDM4EPOLBHSD17B10TP53
SCHEMBL31021114 0.72 SMN1; SMN2 (0.52) KDM4EPOLBHSD17B10TP53LMNA
SCHEMBL537413 0.72 SMN1; SMN2 (0.52) KDM4EPOLBHSD17B10TP53LMNA
SCHEMBL5001588 0.72 KDM4E (0.54) KDM4EPOLBHSD17B10TP53LMNA
SCHEMBL28093697 0.72 MAPT (0.43) KDM4EPOLBHSD17B10TP53LMNA
SCHEMBL19380387 0.71 KDM4E (0.47) PKMKDM4EPOLBLMNAMAPT
Hydrochloric Acid SCHEMBL537828 0.71 SMN1; SMN2 (0.50) KDM4EPOLBHSD17B10TP53LMNA
Hydrochloric Acid SCHEMBL537827 0.71 SMN1; SMN2 (0.50) KDM4EPOLBHSD17B10TP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3374358-A1 AZETIDINE DERIVATIVES FOR TAU IMAGING Eli Lilly and Company (US) 2018-09-19 EP disclosed
WO-2017083198-A1 AZETIDINE DERIVATIVES FOR TAU IMAGING ELI LILLY AND COMPANY (US) 2017-05-18 WO disclosed
US-20070148185-A1 Novel therapeutic target for protozoal diseases VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY 2007-06-28 US disclosed